Roche has scrapped de­vel­op­ment of a mus­cle-build­ing drug, end­ing a tri­al test­ing the ex­per­i­men­tal med­i­cine in com­bi­na­tion with an an­ti-obe­si­ty in­jectable.

The Swiss phar­ma is …

Endpoints News
Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.